Gene: KLHDC9
Official Full Name: kelch domain containing 9provided by HGNC
Gene Summary: Enables cyclin binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27185 | KLHDC9 Knockout cell line (HeLa) | Human | KLHDC9 | 1:3~1:6 | Negative | Online Inquiry |
KO27186 | KLHDC9 Knockout cell line (HEK293) | Human | KLHDC9 | 1:3~1:6 | Negative | Online Inquiry |
KO27187 | KLHDC9 Knockout cell line (A549) | Human | KLHDC9 | 1:3~1:4 | Negative | Online Inquiry |
KLHDC9 Gene Knockout Cell Lines are highly specialized cellular models designed to facilitate the study of the KLHDC9 gene's role in various biological processes. These cell lines are created using advanced CRISPR/Cas9 genome editing technology to induce precise deletions in the KLHDC9 gene. By disrupting the gene's function, researchers can explore its involvement in critical cellular pathways, including those related to cell proliferation, differentiation, and apoptosis.
The innovative design of the KLHDC9 Gene Knockout Cell Lines allows for the straightforward assessment of KLHDC9's functionality through comparative analyses with wild-type cells. The knockout mechanism enables researchers to observe resultant phenotypic changes and molecular alterations, providing insights into the gene's biological significance and potential implications in disease models, particularly in cancer research and metabolic disorders.
In the scientific landscape, these cell lines hold tremendous importance, serving as crucial tools for investigators focused on elucidating gene function, validating drug targets, and screening therapeutic modalities. Their use extends to fundamental research, biomarker discovery, and the development of novel treatment strategies.
Compared to conventional cell line models, KLHDC9 Gene Knockout Cell Lines offer unique advantages such as enhanced specificity of gene disruption, reproducibility in results, and the ability to model loss-of-function scenarios. This precision makes them indispensable in experimental designs seeking to uncover the complexities of gene regulation and interactions.
For researchers and clinical scientists striving for breakthroughs in genetic studies and therapeutic developments, KLHDC9 Gene Knockout Cell Lines represent a valuable resource that can significantly augment experimental impact. Their integration into research protocols will extend the understanding of KLHDC9-related pathways, having far-reaching implications for translational sciences.
Our company specializes in the provision of high-quality gene knockout and transgenic cell line models, backed by a strong commitment to innovation and customer support, making us a leader in the field of biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.